1. Home
  2. BCAL vs VALN Comparison

BCAL vs VALN Comparison

Compare BCAL & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern California Bancorp

BCAL

Southern California Bancorp

HOLD

Current Price

$18.38

Market Cap

578.3M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.10

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCAL
VALN
Founded
2001
2012
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.3M
536.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
BCAL
VALN
Price
$18.38
$6.10
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$20.50
$16.00
AVG Volume (30 Days)
191.8K
137.7K
Earning Date
04-27-2026
05-06-2026
Dividend Yield
2.18%
N/A
EPS Growth
777.27
N/A
EPS
1.93
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.67
$93.87
P/E Ratio
$9.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.37
$5.43
52 Week High
$20.47
$12.25

Technical Indicators

Market Signals
Indicator
BCAL
VALN
Relative Strength Index (RSI) 61.74 28.82
Support Level $17.80 $5.88
Resistance Level $19.31 $6.73
Average True Range (ATR) 0.34 0.28
MACD 0.12 0.04
Stochastic Oscillator 81.34 29.42

Price Performance

Historical Comparison
BCAL
VALN

About BCAL Southern California Bancorp

California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: